U.S. Consumer Durables Stock News

NYSE:WBI
NYSE:WBIEnergy Services

A Look At WaterBridge Infrastructure (WBI) Valuation After Recent Share Price Swings

With no single headline event driving attention today, investors are watching WaterBridge Infrastructure (WBI) following recent price swings and mixed return patterns over the past week, month, and past three months. See our latest analysis for WaterBridge Infrastructure. Over the year to date, WaterBridge Infrastructure’s share price has moved to $21.55, with a 7 day share price return of 6.89% and a 90 day share price return of an 11.75% decline, which suggests recent momentum has cooled...
NasdaqGS:COLL
NasdaqGS:COLLPharmaceuticals

A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Pullback

Event context and recent share performance Collegium Pharmaceutical (COLL) has drawn attention after recent trading, with the share price at US$45.60 and returns showing a 2.8% decline over the past day and 5.3% decline over the past week. See our latest analysis for Collegium Pharmaceutical. While the recent 1 day and 7 day share price returns are negative, the 90 day share price return of 28.96% and 1 year total shareholder return of 36.73% suggest momentum has been building over a longer...
NasdaqGS:UMBF
NasdaqGS:UMBFBanks

Legence And 2 Other Stocks That May Be Priced Below Estimated Value

As the U.S. market grapples with rising Treasury yields and uncertainty surrounding Federal Reserve decisions, investors are keenly observing potential opportunities amid recent index declines. In this environment, identifying undervalued stocks can be crucial for those looking to capitalize on discrepancies between market price and estimated value, as these stocks might offer growth potential despite broader economic challenges.
NasdaqGM:ACRV
NasdaqGM:ACRVBiotechs

Penny Stocks To Watch In January 2026

As the U.S. markets grapple with recent declines and rising Treasury yields, investors are keenly observing potential opportunities in various sectors. Penny stocks, while often seen as relics of past market trends, continue to offer intriguing possibilities for those willing to explore smaller or newer companies at accessible price points. By focusing on solid financials and growth potential, these stocks can present unique opportunities for investors looking to tap into under-the-radar...
NasdaqGS:THFF
NasdaqGS:THFFBanks

US Market's Undiscovered Gems Three Promising Small Caps

As the U.S. market grapples with rising Treasury yields and a cautious Federal Reserve outlook, small-cap stocks are navigating a landscape marked by both challenges and opportunities. In this environment, identifying promising small caps requires a keen eye for companies with robust fundamentals that can weather economic fluctuations and capitalize on niche market demands.
NYSEAM:NBY
NYSEAM:NBYPharmaceuticals

Assessing NovaBay Pharmaceuticals (NBY) Valuation After Digital Asset Financing And SKY Token Treasury Shift

NovaBay Pharmaceuticals (NBY) has reshaped its story with a private placement of pre funded warrants totaling about US$134 million, largely paid in digital assets, and a pivot toward a SKY token focused treasury model. See our latest analysis for NovaBay Pharmaceuticals. The financing news comes after a very sharp 30 day share price return of 178.68% and a very large 1 year total shareholder return, although the 3 and 5 year total shareholder returns are still deeply negative, so long term...
NasdaqGS:ANNX
NasdaqGS:ANNXBiotechs

Annexon (ANNX) Is Up 15.6% After EMA Filing For GBS Antibody Tanruprubart Has The Bull Case Changed?

Annexon, Inc. recently submitted a Marketing Authorization Application to the European Medicines Agency for tanruprubart, a first-in-class antibody targeting complement-driven inflammation in Guillain-Barre syndrome, supported by randomized Phase 3 data and ongoing FORWARD study observations. This move underscores Annexon’s focus on severe neuroinflammatory diseases with limited treatment options, aiming to position tanruprubart as a potential new standard of care in GBS. We’ll now examine...
NasdaqGS:NAVI
NasdaqGS:NAVIConsumer Finance

Navient’s CFO and Oversight Shake-Up Might Change The Case For Investing In Navient (NAVI)

In early January 2026, Navient Corporation reshaped its leadership structure, appointing long-time executive Steve Hauber as Executive Vice President, Chief Financial Officer and Principal Accounting Officer, while Joe Fisher exited the CFO role and began a short transition period before leaving the company. By consolidating finance, legal, risk management, internal audit, and compliance under Hauber and expanding COO Troy Standish’s remit to technology and human resources, Navient is...